New York State Common Retirement Fund Ovid Therapeutics Inc. Transaction History

New York State Common Retirement Fund

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2025	BUY	$0.75 - $1.3 $14,239 - $24,681	18,986 New	18,986 $22,000
Q2 2024 Oct 08, 2025	BUY	$0.7 - $3.34 $13,290 - $63,413	18,986 New	18,986 $14,000
Q2 2024 Jul 31, 2024	BUY	$0.7 - $3.34 $217 - $1,038	311 Added 1.67%	18,986 $15,000
Q1 2024 Oct 08, 2025	BUY	$2.72 - $4.04 $50,796 - $75,447	18,675 New	18,675 $56,000
Q1 2024 May 07, 2024	SELL	$2.72 - $4.04 $835 - $1,240	-307 Reduced 1.62%	18,675 $57,000

Q4 2023 Oct 08, 2025	BUY	$2.98 - $3.78 $56,566 - $71,751	18,982 New	18,982 $61,000
Q4 2023 Feb 01, 2024	SELL	$2.98 - $3.78 $381 - $483	-128 Reduced 0.67%	18,982 $61,000
Q3 2023 Oct 08, 2025	BUY	$3.23 - $3.97 $61,725 - $75,866	19,110 New	19,110 $73,000
Q3 2023 Nov 07, 2023	SELL	$3.23 - $3.97 $24,838 - $30,529	-7,690 Reduced 28.69%	19,110 $73,000
Q2 2023 Oct 08, 2025	BUY	$2.53 - $3.89 $67,804 - $104,252	26,800 New	26,800 $87,000
Q2 2023 Aug 07, 2023	BUY	$2.53 - $3.89 $67,804 - $104,252	26,800 New	26,800 $88,000
Q3 2021 Nov 02, 2021	SELL	$3.31 - $4.04 $1,251 - $1,527	-378 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.3 - $4.49 $127,452 - $173,412	-38,622 Reduced 99.03%	378 $1,000
Q4 2020 Feb 08, 2021	SELL	$2.28 - $6.84 $455 - $1,368	-200 Reduced 0.51%	39,000 $90,000
Q2 2020 Aug 07, 2020	BUY	$2.67 - $7.91 $104,664 - $310,072	39,200 New	39,200 $289,000
Q2 2019 Aug 09, 2019	SELL	$1.59 - $2.14 $12,561 - $16,906	-7,900 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	7,900	7,900 $83,000

33.1M

141K

62.5K

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $92.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.